2026年菸鹼醯胺核苷（NR）全球市場報告

近年來，菸鹼醯胺核苷（NR）市場發展迅速。預計該市場將從2025年的18.1億美元成長到2026年的20.3億美元，複合年成長率（CAGR）為12.5%。過去幾年成長要素包括：膳食補充劑日益普及、消費者對抗衰老方案的興趣日益濃厚、人們對代謝和線粒體健康的關注度不斷提高、線上補充劑銷售管道的拓展，以及對NAD+增強化合物的藥物研發投入活性化。

預計未來幾年菸鹼醯胺核苷 (NR) 市場將快速成長，年複合成長率 (CAGR) 達 12.3%，到 2030 年市場規模將達到 32.3 億美元。預測期內的成長預計將受到以下因素的驅動：對延年益壽和細胞再生產品的需求不斷成長；對個人化健康和精準營養的日益關注；NR 在多成分配方中的應用日益廣泛；透過藥局和專業保健食品商店擴大分銷管道；以及營養保健品和製藥廠商加大投資。預測期內的關鍵趨勢包括：NR 製劑穩定性和生物有效性的技術進步；緩釋膠囊等遞送系統的創新；基於 NR 的機能性食品和飲料添加技術的開發；靶向 NAD+ 通路的治療藥物的研發；以及基於 DNA 和生物標記主導的膳食補充劑技術的進步。

預計未來幾年，消費者健康意識的提升將推動菸鹼醯胺核苷 (NR) 市場的成長。健康意識指的是個人透過生活方式和飲食選擇來維護自身健康的意識和積極行動。這一趨勢源於人們對飲食相關疾病認知的提高，促使更多人選擇營養豐富的食物並減少糖的攝取。健康意識的提升將透過增加對支持細胞能量、健康老齡化和代謝功能的補充劑的需求，促進 NR 的普及。此外，它還將透過增強積極的健康促進行為和提高對經科學驗證的營養成分的興趣來推動市場成長。例如，總部位於美國的非營利組織國際食品資訊理事會 (IFIC) 在 2024 年 6 月報告稱，關注增加蛋白質攝取量的美國人比例從 2022 年的 59% 上升到 2023 年的 67%，並在 2024 年達到 71%。因此，消費者健康意識的提升正在推動 NR 市場的成長。

煙醯胺核苷 (NR) 市場的主要企業正致力於開發先進配方，例如煙醯胺腺嘌呤二核苷酸 (NAD+)護膚補充劑，以促進抗衰老並改善皮膚健康。 NAD+護膚補充劑是口服或外用產品，旨在透過提高皮膚細胞中的 NAD+ 水平，並支持細胞能量、修復和抗衰老過程，從而改善皮膚健康和外觀。例如，2024 年 4 月，總部位於美國的 NAD+ 生物科技公司 ChromaDex Corporation 在 The Vitamin Shoppe 推出了「Tru Niagen」。這款促進健康老化的 NAD+ 補充劑旨在安全有效地提高成人體內的 NAD+ 水平，從而支持細胞健康、能量產生和整體健康。該產品已在全美範圍內上市，使尋求科學支持以應對與老齡化相關的代謝衰退的消費者能夠廣泛購買到它。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球菸鹼醯胺核苷 (NR) 市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 永續性、氣候技術、循環經濟
  • 數位化、雲端運算、巨量資料、網路安全
  • 人工智慧（AI）和自主人工智慧
  • 工業4.0和智慧製造
• 主要趨勢
  • 含有NR的營養補充品越來越受歡迎。
  • 對粒線體健康產品的需求日益成長
  • 擴大天然橡膠在機能性食品和飲料的應用
  • 拓展促進健康老齡化的配方。
  • 人們越來越關注生物有效性和吸收率

第5章 終端用戶產業市場分析

• 健身愛好者
• 高齡化社會
• 一般消費者
• 醫療機構
• 研究和學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球菸鹼醯胺核苷 (NR) 市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 全球菸鹼醯胺核苷 (NR) 市場規模、對比及成長率分析
• 全球菸鹼醯胺核苷 (NR) 市場表現：規模與成長，2020-2025 年
• 全球煙鹼醯胺核苷 (NR) 市場預測：規模和成長，2025-2030 年，2035 年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依產品類型
• 膠囊、錠劑、粉末及其他產品類型
• 透過分銷管道
• 線上零售商、健康保健商店、藥局、超級市場和大賣場、專賣店
• 透過使用
• 營養補充品、藥品、化妝品和個人保健產品、食品和飲料、動物飼料
• 最終用戶
• 健身愛好者、老年人群、一般消費者、醫療機構、研究和學術機構
• 按類型細分：膠囊
• 素食膠囊、明膠膠囊、緩釋膠囊、即溶膠囊、腸溶膠囊
• 按類型細分：片劑
• 包衣片、咀嚼片、發泡、舌下片、緩釋片
• 按類型細分：粉末
• 調味粉、無味粉、水溶粉、發泡粉、單份包裝粉劑。
• 按類型細分：其他產品類型
• 軟膠囊、口服液、軟糖、機能飲料、營養強化食品

第10章 區域與國別分析

• 全球菸鹼醯胺核苷 (NR) 市場：按地區分類，歷史資料及預測，2020-2025 年、2025-2030 年、2035 年
• 全球菸鹼醯胺核苷 (NR) 市場：依國家分類，歷史資料及預測，2020-2025 年、2025-2030 年、2035 年

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 菸鹼醯胺核苷（NR）市場：競爭格局及市場佔有率，2024年
• 煙鹼醯胺核苷 (NR) 市場：公司估值矩陣
• 煙鹼醯胺核苷（NR）市場：公司簡介
  • Zhejiang NHU Company Ltd.
  • Designs for Health Inc.
  • Niagen Bioscience Inc.
  • Cayman Chemical Company
  • Jinan Qinmu Fine Chemical Co. Ltd

第37章 其他大型企業和創新企業

• Simson Pharma Limited, Runtai Chemical, Double Wood Supplements LLC, DoNotAge.org Ltd., Bontac Bio-engineering（Shenzhen）Co. Ltd., Hangzhou Longshine Bio-Tech Co. LTD, Renue By Science LLC, Kavya Pharma, China Qingdao Hong Jin Chemical Co. Ltd., Chemvon Biotechnology（Shanghai）Co. Ltd., Dravyom Chemical Company, Fengchen Group Co. Ltd, Hangzhou Weitai Biological Pharmaceutical Co. Ltd., Suzhou Myland Nutraceuticals Inc., Chromadex Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：具有高市場潛力的國家、細分市場與策略

• 2030年菸鹼醯胺核苷（NR）市場：提供新機會的國家
• 2030年菸鹼醯胺核苷（NR）市場：蘊藏新機會的細分市場
• 2030年菸鹼醯胺核苷（NR）市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第41章附錄

Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3 and a precursor to nicotinamide adenine dinucleotide (NAD+), an essential coenzyme in cellular energy metabolism. Its main function is to increase NAD+ levels in cells, supporting mitochondrial function, energy production, and healthy aging. NR is commonly used as a dietary supplement to improve metabolic health and promote overall cellular vitality.

The primary product types of nicotinamide riboside (NR) products include capsules, tablets, powders, and other product types. Capsules refer to orally administered nicotinamide riboside formulations designed to support cellular energy metabolism, healthy aging, and overall wellness. The distribution channels include online retail, health and wellness stores, pharmacies and drugstores, supermarkets and hypermarkets, and specialty stores. The applications span dietary supplements, pharmaceuticals, cosmetics and personal care products, food and beverage, and animal nutrition, and the key users are across dietary supplements, pharmaceuticals, cosmetics and personal care products, food and beverage, and animal nutrition.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are influencing the nicotinamide riboside market by increasing costs of imported active ingredients, encapsulation materials, analytical testing services, and nutraceutical manufacturing equipment. north america and europe are most affected due to reliance on cross-border sourcing of high-purity nr compounds, while asia-pacific faces cost pressure on contract manufacturing and exports. these tariffs are elevating retail prices and impacting margins for supplement brands. at the same time, they are encouraging domestic synthesis of nr, regional supply chain development, and investment in localized nutraceutical manufacturing infrastructure.

The nicotinamide riboside (nr) market research report is one of a series of new reports from The Business Research Company that provides nicotinamide riboside (nr) market statistics, including nicotinamide riboside (nr) industry global market size, regional shares, competitors with a nicotinamide riboside (nr) market share, detailed nicotinamide riboside (nr) market segments, market trends and opportunities, and any further data you may need to thrive in the nicotinamide riboside (nr) industry. This nicotinamide riboside (nr) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nicotinamide riboside (NR) market size has grown rapidly in recent years. It will grow from $1.81 billion in 2025 to $2.03 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to increasing adoption of nutraceutical supplements, growing consumer interest in anti-aging solutions, rising awareness of metabolic and mitochondrial health, expansion of online supplement sales channels, increasing pharmaceutical research on NAD+ boosting compounds.

The nicotinamide riboside (NR) market size is expected to see rapid growth in the next few years. It will grow to $3.23 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to growing demand for longevity and cellular rejuvenation products, increasing interest in personalized wellness and precision nutrition, rising incorporation of NR into multi-ingredient formulations, expansion of distribution across pharmacies and specialty health stores, growing investments from nutraceutical and pharmaceutical manufacturers. Major trends in the forecast period include technology advancements in nr formulation stability and bioavailability, innovations in delivery systems such as sustained release capsules, developments in functional food and beverage fortification with nr, research and development in nad+ pathway therapeutics, advancements in DNA-based and biomarker-driven supplement customization.

The increasing health consciousness among consumers is expected to drive the growth of the nicotinamide riboside (NR) market in the coming years. Health consciousness refers to individuals' awareness and proactive approach toward maintaining good health through lifestyle and dietary choices. This trend is rising due to greater awareness of diet-related diseases, encouraging more people to select nutritious foods and reduce sugar intake. Health consciousness boosts NR adoption by increasing demand for supplements that support cellular energy, healthy aging, and metabolic function. It promotes market growth by fostering proactive wellness behaviors and interest in scientifically validated nutritional ingredients. For example, in June 2024, the International Food Information Council, a US-based nonprofit organization, reported that the proportion of Americans focusing on consuming more protein increased from 59% in 2022 to 67% in 2023 and 71% in 2024. Consequently, the growing health consciousness among consumers is fueling the growth of the NR market.

Leading companies in the nicotinamide riboside (NR) market are focusing on developing advanced formulations, such as nicotinamide adenine dinucleotide (NAD+) skincare supplements, to promote anti-aging and enhance skin health. NAD+ skincare supplements are dietary or topical products designed to boost NAD+ levels in skin cells, supporting cellular energy, repair, and anti-aging processes to improve skin health and appearance. For example, in April 2024, ChromaDex Corporation, a US-based NAD+ bioscience company, launched Tru Niagen at The Vitamin Shoppe. This healthy-aging NAD+ supplement is formulated to safely and effectively elevate NAD+ levels in adults, supporting cellular health, energy production, and overall well-being. The nationwide rollout makes the product widely accessible to consumers seeking science-based support for age-related declines in metabolic function.

In October 2023, L Catterton Management Company LLC, a US-based consumer-focused investment firm, acquired Thorne HealthTech Inc. for an undisclosed sum. This acquisition allowed L Catterton to expand its presence in the personalized wellness and longevity-focused nutrition markets by leveraging Thorne's established product portfolio, research and development capabilities, and direct-to-consumer reach. Thorne HealthTech Inc. is a US-based nutritional supplement company specializing in nicotinamide riboside (NR) products that support cellular health and healthy aging.

Major companies operating in the nicotinamide riboside (nr) market are Zhejiang NHU Company Ltd., Designs for Health Inc., Niagen Bioscience Inc., Cayman Chemical Company, Jinan Qinmu Fine Chemical Co. Ltd, Simson Pharma Limited, Runtai Chemical, Double Wood Supplements LLC, DoNotAge.org Ltd., Bontac Bio-engineering (Shenzhen) Co. Ltd., Hangzhou Longshine Bio-Tech Co. LTD, Renue By Science LLC, Kavya Pharma, China Qingdao Hong Jin Chemical Co. Ltd., Chemvon Biotechnology (Shanghai) Co. Ltd., Dravyom Chemical Company, Fengchen Group Co. Ltd, Hangzhou Weitai Biological Pharmaceutical Co. Ltd., Suzhou Myland Nutraceuticals Inc., Chromadex Inc.

North America was the largest region in the nicotinamide riboside market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nicotinamide riboside (nr) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nicotinamide riboside (nr) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nicotinamide riboside (NR) market consists of sales of capsules, tablets, and powder supplements. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nicotinamide Riboside (NR) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses nicotinamide riboside (nr) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nicotinamide riboside (nr) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nicotinamide riboside (nr) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Capsules; Tablets; Powders; Other Product Types
• 2) By Distribution Channel: Online Retail; Health and Wellness Stores; Pharmacies and Drugstores; Supermarkets and Hypermarkets; Specialty Stores
• 3) By Application: Dietary Supplements; Pharmaceuticals; Cosmetics and Personal Care Products; Food and Beverage; Animal Nutrition
• 4) By End-User: Fitness Enthusiasts; Aging Population; General Consumers; Healthcare Institutions; Research and Academic Institutions
• Subsegments:
• 1) By Capsules: Vegetarian Capsules; Gelatin Capsules; Sustained Release Capsules; Fast Dissolution Capsules; Enteric Coated Capsules
• 2) By Tablets: Coated Tablets; Chewable Tablets; Effervescent Tablets; Sublingual Tablets; Extended Release Tablets
• 3) By Powders: Flavored Powders; Unflavored Powders; Water Soluble Powders; Effervescent Powders; Single Serve Sachet Powders
• 4) By Other Product Types: Softgels; Liquid Oral Drops; Gummies; Functional Beverages; Fortified Food Products
• Companies Mentioned: Zhejiang NHU Company Ltd.; Designs for Health Inc.; Niagen Bioscience Inc.; Cayman Chemical Company; Jinan Qinmu Fine Chemical Co. Ltd; Simson Pharma Limited; Runtai Chemical; Double Wood Supplements LLC; DoNotAge.org Ltd.; Bontac Bio-engineering (Shenzhen) Co. Ltd.; Hangzhou Longshine Bio-Tech Co. LTD; Renue By Science LLC; Kavya Pharma; China Qingdao Hong Jin Chemical Co. Ltd.; Chemvon Biotechnology (Shanghai) Co. Ltd.; Dravyom Chemical Company; Fengchen Group Co. Ltd; Hangzhou Weitai Biological Pharmaceutical Co. Ltd.; Suzhou Myland Nutraceuticals Inc.; Chromadex Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Nicotinamide Riboside (NR) Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Nicotinamide Riboside (NR) Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Nicotinamide Riboside (NR) Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Nicotinamide Riboside (NR) Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Sustainability, Climate Tech & Circular Economy
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Increasing Popularity Of Nr-Based Dietary Supplements
  • 4.2.2 Rising Demand For Mitochondrial Health Products
  • 4.2.3 Growing Use Of Nr In Functional Foods And Beverages
  • 4.2.4 Expansion Of Healthy Aging Formulations
  • 4.2.5 Enhanced Focus On Bioavailability And Absorption

5. Nicotinamide Riboside (NR) Market Analysis Of End Use Industries

• 5.1 Fitness Enthusiasts
• 5.2 Aging Population
• 5.3 General Consumers
• 5.4 Healthcare Institutions
• 5.5 Research And Academic Institutions

6. Nicotinamide Riboside (NR) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Nicotinamide Riboside (NR) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Nicotinamide Riboside (NR) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Nicotinamide Riboside (NR) Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Nicotinamide Riboside (NR) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Nicotinamide Riboside (NR) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Nicotinamide Riboside (NR) Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Nicotinamide Riboside (NR) Market Segmentation

• 9.1. Global Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Capsules, Tablets, Powders, Other Product Types
• 9.2. Global Nicotinamide Riboside (NR) Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Online Retail, Health and Wellness Stores, Pharmacies and Drugstores, Supermarkets and Hypermarkets, Specialty Stores
• 9.3. Global Nicotinamide Riboside (NR) Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Dietary Supplements, Pharmaceuticals, Cosmetics and Personal Care Products, Food and Beverage, Animal Nutrition
• 9.4. Global Nicotinamide Riboside (NR) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fitness Enthusiasts, Aging Population, General Consumers, Healthcare Institutions, Research and Academic Institutions
• 9.5. Global Nicotinamide Riboside (NR) Market, Sub-Segmentation Of Capsules, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Vegetarian Capsules, Gelatin Capsules, Sustained Release Capsules, Fast Dissolution Capsules, Enteric Coated Capsules
• 9.6. Global Nicotinamide Riboside (NR) Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Coated Tablets, Chewable Tablets, Effervescent Tablets, Sublingual Tablets, Extended Release Tablets
• 9.7. Global Nicotinamide Riboside (NR) Market, Sub-Segmentation Of Powders, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Flavored Powders, Unflavored Powders, Water Soluble Powders, Effervescent Powders, Single Serve Sachet Powders
• 9.8. Global Nicotinamide Riboside (NR) Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Softgels, Liquid Oral Drops, Gummies, Functional Beverages, Fortified Food Products

10. Nicotinamide Riboside (NR) Market Regional And Country Analysis

• 10.1. Global Nicotinamide Riboside (NR) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Nicotinamide Riboside (NR) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Nicotinamide Riboside (NR) Market

• 11.1. Asia-Pacific Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Nicotinamide Riboside (NR) Market

• 12.1. China Nicotinamide Riboside (NR) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Nicotinamide Riboside (NR) Market

• 13.1. India Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Nicotinamide Riboside (NR) Market

• 14.1. Japan Nicotinamide Riboside (NR) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Nicotinamide Riboside (NR) Market

• 15.1. Australia Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Nicotinamide Riboside (NR) Market

• 16.1. Indonesia Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Nicotinamide Riboside (NR) Market

• 17.1. South Korea Nicotinamide Riboside (NR) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Nicotinamide Riboside (NR) Market

• 18.1. Taiwan Nicotinamide Riboside (NR) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Nicotinamide Riboside (NR) Market

• 19.1. South East Asia Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Nicotinamide Riboside (NR) Market

• 20.1. Western Europe Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Nicotinamide Riboside (NR) Market

• 21.1. UK Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Nicotinamide Riboside (NR) Market

• 22.1. Germany Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Nicotinamide Riboside (NR) Market

• 23.1. France Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Nicotinamide Riboside (NR) Market

• 24.1. Italy Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Nicotinamide Riboside (NR) Market

• 25.1. Spain Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Nicotinamide Riboside (NR) Market

• 26.1. Eastern Europe Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Nicotinamide Riboside (NR) Market

• 27.1. Russia Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Nicotinamide Riboside (NR) Market

• 28.1. North America Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Nicotinamide Riboside (NR) Market

• 29.1. USA Nicotinamide Riboside (NR) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Nicotinamide Riboside (NR) Market

• 30.1. Canada Nicotinamide Riboside (NR) Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Nicotinamide Riboside (NR) Market

• 31.1. South America Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Nicotinamide Riboside (NR) Market

• 32.1. Brazil Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Nicotinamide Riboside (NR) Market

• 33.1. Middle East Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Nicotinamide Riboside (NR) Market

• 34.1. Africa Nicotinamide Riboside (NR) Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Nicotinamide Riboside (NR) Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Nicotinamide Riboside (NR) Market Regulatory and Investment Landscape

36. Nicotinamide Riboside (NR) Market Competitive Landscape And Company Profiles

• 36.1. Nicotinamide Riboside (NR) Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Nicotinamide Riboside (NR) Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Nicotinamide Riboside (NR) Market Company Profiles
  • 36.3.1. Zhejiang NHU Company Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Designs for Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Niagen Bioscience Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Cayman Chemical Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Jinan Qinmu Fine Chemical Co. Ltd Overview, Products and Services, Strategy and Financial Analysis

37. Nicotinamide Riboside (NR) Market Other Major And Innovative Companies

• Simson Pharma Limited, Runtai Chemical, Double Wood Supplements LLC, DoNotAge.org Ltd., Bontac Bio-engineering (Shenzhen) Co. Ltd., Hangzhou Longshine Bio-Tech Co. LTD, Renue By Science LLC, Kavya Pharma, China Qingdao Hong Jin Chemical Co. Ltd., Chemvon Biotechnology (Shanghai) Co. Ltd., Dravyom Chemical Company, Fengchen Group Co. Ltd, Hangzhou Weitai Biological Pharmaceutical Co. Ltd., Suzhou Myland Nutraceuticals Inc., Chromadex Inc.

38. Global Nicotinamide Riboside (NR) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Nicotinamide Riboside (NR) Market

40. Nicotinamide Riboside (NR) Market High Potential Countries, Segments and Strategies

• 40.1 Nicotinamide Riboside (NR) Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Nicotinamide Riboside (NR) Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Nicotinamide Riboside (NR) Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer